microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
about
Searching for the 'melano-miRs': miR-214 drives melanoma metastasisMicroRNAs in colorectal cancer: role in metastasis and clinical perspectivesEpigenetic regulation in human melanoma: past and futureMicroRNA-214 Is Upregulated in Heart Failure Patients and Suppresses XBP1-Mediated Endothelial Cells AngiogenesisPhosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cellsMiR-214 promotes the alcohol-induced oxidative stress via down-regulation of glutathione reductase and cytochrome P450 oxidoreductase in liver cellsControl by a hair's breadth: the role of microRNAs in the skinNCK Associated Protein 1 Modulated by miRNA-214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia.Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression.Modulation of microRNA expression in human lung cancer cells by the G9a histone methyltransferase inhibitor BIX01294.ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer.A novel miR-451a isomiR, associated with amelanotypic phenotype, acts as a tumor suppressor in melanoma by retarding cell migration and invasionmiR-214 targets ATF4 to inhibit bone formation.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseasesMiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanomaRegulation of NANOG in cancer cells.miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancerIn-depth characterization of microRNA transcriptome in melanoma.Human Melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C.Novel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance.Exosomal and Non-Exosomal Transport of Extra-Cellular microRNAs in Follicular Fluid: Implications for Bovine Oocyte Developmental Competence.MicroRNA-214 suppresses oncogenesis and exerts impact on prognosis by targeting PDRG1 in bladder cancer.Clinicopathological significance of microRNA-214 in gastric cancer and its effect on cell biological behaviour.Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.Identification of a novel miRNA from the ovine ovary by a combinatorial approach of bioinformatics and experiments.An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.The roles of microRNAs in the regulation of tumor metastasis.Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b.MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.CyTRANSFINDER: a Cytoscape 3.3 plugin for three-component (TF, gene, miRNA) signal transduction pathway construction.Epigenetic biomarkers in skin cancer.miR-214-mediated downregulation of RNF8 induces chromosomal instability in ovarian cancer cellsSmall RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells--Evidence of unique microRNA cargos.Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma.MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.Current status and implications of microRNAs in ovarian cancer diagnosis and therapy.Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication.
P2860
Q24632823-0B6C736F-91B0-4CDD-83CD-C26776814D17Q27022292-3BB6AF03-F1ED-4B90-A7CA-557300D79FF6Q28085681-509BCAF1-1CA8-4317-A817-A43B63C3292CQ28115504-5C985A02-D30F-4D7B-B7C5-F955C3250AC0Q28384799-F8A66F78-7CA1-4A11-98A8-440886FA75FDQ28569223-FACFB471-118D-4D2E-AC56-3CD8FB91E723Q28709944-BFD30668-272D-4679-B3AC-49F539455DE3Q29871102-39A74CE1-57AB-4067-BB89-39196493B5F7Q30276253-B26B84DA-1600-4904-94FA-B065EBBCEAFAQ33677872-FDFF3148-17DE-4E7B-B1E8-9BC16C0D1BFDQ33727680-C06968C5-44A9-413B-B44E-2553C8BFCDCEQ34168267-330C950B-C7E5-47E1-8864-2A4BD6C20258Q34215802-A21FD293-0C17-4F2A-A1E1-4B61158F5AD3Q34316430-0C416A79-4CB7-4B4C-A460-59FDC2A4DFE8Q34391443-8E5EF39B-E93F-47E0-AC8B-52973D7AFC7FQ34409807-7C6DFF9C-F4BF-4329-A295-E9EF294AD809Q34459058-2E423CE1-99C6-4767-BE67-FFD70040C00CQ34478004-CA237533-432F-47A9-9237-BBF2A373D9E3Q34490836-0105EBEF-9FA8-464B-A05A-760302E86F43Q34984013-148A419F-55E7-41DB-B9B1-7A286F15D65DQ34984600-890B4C36-F00B-4C8D-87A7-82DA017C9A81Q35017844-D83A2F1E-AE59-456D-BBA5-F03C488C2EFEQ35040950-AA9C8AB0-69D0-42D8-B936-A6039FCD7FE9Q35113163-6F9AEF9A-60A7-4319-8047-06AA2EA2C6DCQ35116221-D4475128-585B-4A2A-A446-9B728F462FD4Q35571900-F0ED158C-BEB5-44EC-ACCC-6D8B21AB8387Q35735278-B009A8D9-2819-42CA-8147-D7C96DF7B644Q35744525-5875DEA2-CF20-4C8A-A945-939F54B350D5Q35811250-251B72BC-7DCA-4CFB-9CF9-C2EB2C7E19F9Q35816884-BEFBBF35-828F-4264-A37A-D22FF710BD77Q35833167-CF7C4964-0743-46C1-80F6-17D9EF4BC529Q35922278-567C2760-6630-4652-B8CD-7206509D4AFAQ35984089-05B1F1E4-5A78-4A7C-A2E7-90FE8E794C5FQ36080974-D85FDECB-9D38-4775-92FA-DF928AF8D91CQ36189350-60943D5D-ABD3-4AC8-AE5E-350B257A5F6EQ36191656-E9DCCE90-F8D2-4186-B2ED-FEF3559147B1Q36270963-52E86571-9B8C-4105-816E-AA0D7F209348Q36318784-ECD6C55B-454E-4FD0-A970-A1A0AF468101Q36517492-4AE1E65F-449E-4E7D-8D6F-13CD33BDEAFEQ36862536-002F437B-328E-4AE0-B98E-23D69213BCE5
P2860
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
@ast
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
@en
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
@nl
type
label
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
@ast
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
@en
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
@nl
prefLabel
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
@ast
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
@en
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.
@nl
P2093
P2860
P50
P356
P1433
P1476
microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C
@en
P2093
Adele Haimovic
Antonio Lembo
Daniela Cimino
Elisa Penna
Enrico Tenaglia
Francesca Orso
Iman Osman
Maria Grazia Bernengo
Michael B Stadler
Paolo Provero
P2860
P304
P356
10.1038/EMBOJ.2011.102
P407
P577
2011-04-05T00:00:00Z